Glenmark and BeiGene partner to market cancer drugs in India
Both the companies enter into an agreement for marketing and distribution of Tislelizumab and Zanubrutinib in India
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
tislelizumab
Novartis’s tislelizumab phase-III trial data shows survival results in esophageal cancer
First-line tislelizumab plus chemotherapy showed median Overall Survival (OS) of 17.2 months versus 10.6 months for chemotherapy…